Travere (TVTX) Stock Soared On Analyst Upgrade
Fahim Awan
December 6, 2023
Travere Therapeutics, Inc. (NASDAQ: TVTX) experienced a notable surge of 17.65%, concluding the previous session at $7.40. This upswing ensued subsequent to an upgraded recommendation